Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimating vaccine efficacy using auxiliary outcome data and a small validation sample.

Haitao Chu1, M Elizabeth Halloran

  • 1Department of Biostatistics, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA. hchu@jhsph.edu

Statistics in Medicine
|August 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Evidence Synthesis of Adverse Events in Imbalanced Time-to-Event Data.

Journal of evidence-based medicine·2026
Same author

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease.

Frontiers in immunology·2026
Same author

Trial design-aware funnel plot for publication bias assessment with noninferiority or equivalence objectives.

Journal of clinical epidemiology·2026
Same author

Unpublished trials affected evidence synthesis substantially when estimating medication harms in children.

Journal of clinical epidemiology·2026
Same author

The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons.

Research synthesis methods·2026
Same author

Minimum distance estimation of mean and standard deviation from reported quantiles.

Research synthesis methods·2026
Same journal

Checking Genetic Homogeneity Between Two Samples Using Summary Statistics With Application to Mendelian Randomization.

Statistics in medicine·2026
Same journal

A Bayesian Learning Model for Joint Risk Prediction of Alcohol and Cannabis Use Disorders.

Statistics in medicine·2026
Same journal

Reluctant Transfer Learning in Penalized Regressions for Individualized Treatment Rules Under Effect Heterogeneity.

Statistics in medicine·2026
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
See all related articles

This study introduces a Bayesian method to accurately estimate vaccine efficacy using auxiliary outcome data and small validation sets. This approach overcomes limitations of traditional methods when specific outcomes are negative, improving statistical efficiency.

Area of Science:

  • Biostatistics
  • Vaccinology
  • Epidemiology

Background:

  • Diagnosing infectious agents in vaccine studies via culture or serology is costly and challenging.
  • Validation sets, using auxiliary outcomes on all participants and specific outcomes on a subset, offer a cost-effective alternative.
  • Relying solely on auxiliary outcomes can attenuate vaccine efficacy estimates.

Purpose of the Study:

  • To propose a novel Bayesian method for estimating vaccine efficacy and its highest probability density (HPD) credible set.
  • To address challenges in vaccine efficacy estimation when using auxiliary outcome data and small validation sets, particularly when specific outcomes are negative.
  • To compare the proposed Bayesian method with traditional missing data techniques like mean score and multiple imputation.

Main Methods:

Related Experiment Videos

  • Development of a Bayesian approach utilizing Monte Carlo (MC) methods for vaccine efficacy estimation.
  • Application of the Bayesian method to auxiliary outcome data from participants and specific outcomes from a small validation sample.
  • Comparison with mean score and multiple imputation methods, noting their reliance on continuity corrections and potentially violated normality assumptions.

Main Results:

  • The proposed Bayesian method effectively estimates vaccine efficacy and HPD credible sets, even with small validation samples and negative specific outcomes.
  • Traditional methods (mean score, multiple imputation) may require ad hoc continuity corrections and rely on normality assumptions that can be problematic.
  • Comparative analysis using influenza vaccine field data and simulations demonstrated the superiority of the Bayesian approach in this context.

Conclusions:

  • The Bayesian method provides a statistically efficient and robust approach for estimating vaccine efficacy when employing validation sets with auxiliary outcomes.
  • This method is particularly recommended when validation sample sizes are small and the vaccine demonstrates high efficacy, leading to predominantly negative specific outcomes.
  • The Bayesian framework offers a reliable alternative to traditional missing data techniques, mitigating bias and improving precision in vaccine efficacy studies.